• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $BLI

    Berkeley Lights Inc.

    Subscribe to $BLI
    $BLI
    Medicinal Chemicals and Botanical Products
    Health Care

    Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. The company was incorporated in 2011 and is headquartered in Emeryville, California.

    IPO Year: 2020

    Exchange: NASDAQ

    Website: berkeleylights.com

    Recent Analyst Ratings for Berkeley Lights Inc.

    DatePrice TargetRatingAnalyst
    8/10/2022$10.00 → $5.00Equal-Weight → Underweight
    Morgan Stanley
    8/10/2022Buy → Neutral
    BTIG Research
    8/10/2022$12.00 → $8.00Overweight → Neutral
    JP Morgan
    3/2/2022Outperform
    Cowen
    2/25/2022$20.00 → $14.00Equal-Weight
    Morgan Stanley
    2/15/2022$36.00 → $20.00Equal-Weight
    Morgan Stanley
    1/6/2022$61.00 → $12.00Buy → Hold
    Stifel
    1/6/2022Outperform → Mkt Perform
    William Blair
    1/6/2022$61.00 → $12.00Hold → Sell
    Stifel
    10/15/2021Outperform
    Cowen
    See more ratings

    Berkeley Lights Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Berkeley Lights downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Berkeley Lights from Equal-Weight to Underweight and set a new price target of $5.00 from $10.00 previously

      8/10/22 9:27:59 AM ET
      $BLI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Berkeley Lights downgraded by BTIG Research

      BTIG Research downgraded Berkeley Lights from Buy to Neutral

      8/10/22 7:24:20 AM ET
      $BLI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Berkeley Lights downgraded by JP Morgan with a new price target

      JP Morgan downgraded Berkeley Lights from Overweight to Neutral and set a new price target of $8.00 from $12.00 previously

      8/10/22 6:23:47 AM ET
      $BLI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cowen resumed coverage on Berkeley Lights

      Cowen resumed coverage of Berkeley Lights with a rating of Outperform

      3/2/22 8:40:53 AM ET
      $BLI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Morgan Stanley reiterated coverage on Berkeley Lights with a new price target

      Morgan Stanley reiterated coverage of Berkeley Lights with a rating of Equal-Weight and set a new price target of $14.00 from $20.00 previously

      2/25/22 8:24:00 AM ET
      $BLI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Morgan Stanley reiterated coverage on Berkeley Lights with a new price target

      Morgan Stanley reiterated coverage of Berkeley Lights with a rating of Equal-Weight and set a new price target of $20.00 from $36.00 previously

      2/15/22 9:30:04 AM ET
      $BLI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Berkeley Lights downgraded by Stifel with a new price target

      Stifel downgraded Berkeley Lights from Buy to Hold and set a new price target of $12.00 from $61.00 previously

      1/6/22 8:32:37 AM ET
      $BLI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Berkeley Lights downgraded by William Blair

      William Blair downgraded Berkeley Lights from Outperform to Mkt Perform

      1/6/22 7:36:38 AM ET
      $BLI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Berkeley Lights downgraded by Stifel with a new price target

      Stifel downgraded Berkeley Lights from Hold to Sell and set a new price target of $12.00 from $61.00 previously

      1/6/22 7:15:42 AM ET
      $BLI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Cowen resumed coverage on Berkeley Lights

      Cowen resumed coverage of Berkeley Lights with a rating of Outperform

      10/15/21 7:17:42 AM ET
      $BLI
      Medicinal Chemicals and Botanical Products
      Health Care